Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Altana Innovationsfonds is the corporate venture capital arm of ALTANA AG, a global leader in specialty chemicals. The fund focuses on strategic investments in young, high-growth companies that align with ALTANA's core competencies in materials science and functional chemistry. Key areas of investment include biotechnology, printed electronics, 3D printing, and digital transformation within the chemical industry. By providing both capital and access to the parent company's extensive research and development infrastructure, the fund fosters innovation in sustainable and high-tech applications. While ALTANA divested its primary pharmaceutical business in 2007, the Innovationsfonds remains active in life science sectors where specialty materials and chemical processes are critical to medical technology and bio-based solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Altana Innovationsfonds.